JMP Securities Initiates Coverage On AN2 Therapeutics With Market Outperform Rating, Announces Price Target of $30
JMP Securities Initiates Coverage On AN2 Therapeutics With Market Outperform Rating, Announces Price Target of $30
JMP證券以市場跑贏大盤的評級啓動對AN2療法的報道,宣佈目標股價爲30美元
JMP Securities analyst Roy Buchanan initiates coverage on AN2 Therapeutics (NASDAQ:ANTX) with a Market Outperform rating and announces Price Target of $30.
JMP Securities分析師羅伊·布坎南以市場跑贏大盤的評級啓動了對AN2 Therapeutics(納斯達克股票代碼:ANTX)的報道,並宣佈目標股價爲30美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。